ReviewFrontiers in aging neuroscience2022

Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer's Disease: A Focus on Aducanumab and Lecanemab.

Mingchao Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.